Loading…
Medicare Patient Access to Cancer Treatment Act of 2013
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
37pct
2d open
vs 5,821 other HR bills in the 113th — cohort avg 49d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (15)
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2014 · fourth_quarter · Medicare/Medicaid
HR 800 S 806 -- Amends Part B (Supplementary Medical Insurance) of Title XVIII (Medicare) of the Social Security Act to exclude from the average sales price in calculating Medicare payments for drugs and biologicals any customary prompt pay discounts from manufacturers to wholesalers. HR 2869 - To amend Title XVIII of the Social Security Act to establish payment parity under the Medicare program for ambulatory cancer care services furnished in the hospital outpatient department and the physician office setting.
Client expense: Not reported · Firm income: $13,500
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Health Issues
HR 800, prompt pay legislation; health IT and meaningful use; radiation and reimbursement issues; SGR Medicare physician payments; H.R.1416 Cancer Patient Protection Act of 2013; H.R. 2869, Medicare Patient Access to Cancer Treatment Act of 2013
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Medicare/Medicaid
Physician and pharmacy reimbursement issues. Implementation of the Affordable Care Act. H.R. 2869 "Medicare Patient Access to Cancer Treatment Act of 2013" H R 4302 "Protecting Access to Medicare Act of 2014" (PL 113-93) S.806/H.R.800 "To amend Part B of title XVII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biological under Medicare"
Client expense: $338,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Medicare/Medicaid
Physician and pharmacy reimbursement issues. Implementation of the Affordable Care Act. H.R. 2869 "Medicare Patient Access to Cancer Treatment Act of 2013" H R 4302 "Protecting Access to Medicare Act of 2014" (PL 113-93)
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Medicare/Medicaid
medicare, oncology, radiation and imaging reimbursement issues; medicare physician payments; health information technology; application of the sequester to cancer drug reimbursement (HR 1416 - the Cancer Patient Protection Act of 2013); prompt pay discount (HR 800 Prompt Pay Discount Legislation); safety and security of the prescription drug supply chain. Oncology payment disparities in Medicare (HR 2869)
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
| Republican |
| CO |
| Renee L. Ellmers | Republican | NC |
| Trey Radel | Republican | FL |
2014 · third_quarter · Health Issues
HR 800, prompt pay legislation; health IT and meaningful use; radiation and reimbursement issues; SGR Medicare physician payments; H.R.1416 Cancer Patient Protection Act of 2013; H.R. 2869, Medicare Patient Access to Cancer Treatment Act of 2013
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Medicare/Medicaid
HR800/S806 - Amends part B (Supplementary Medical Insurance) of title XVIII (Medicare) of the Social Security Act to exclude from the average sales price in calculating Medicare payments for drugs and biologicals any customary prompt pay discounts from manufacturers to wholesalers. HR2869 - To amend title XVIII of the Social Security Act to establish payment parity under the Medicare program for ambulatory cancer care services furnished in the hospital outpatient department and the physician office setting. Opposition to proposed Medicare cuts to radiation oncology services due to removal of radiation treatment vault as a direct practice expense input. No specific legislation.
Client expense: Not reported · Firm income: $13,500
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Medicare/Medicaid
Physician and pharmacy reimbursement issues. Implementation of the Affordable Care Act. H.R. 2869 "Medicare Patient Access to Cancer Treatment Act of 2013" H R 4302 "Protecting Access to Medicare Act of 2014" (PL 113-93) H.R. 1416 "Cancer Patient Protection Act of 2013"S.806/H.R.800 "To amend Part B of title XVII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biological under Medicare"
Client expense: $240,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2014 · third_quarter · Medicare/Medicaid
Physician and pharmacy reimbursement issues. Implementation of the Affordable Care Act. H.R. 2869 "Medicare Patient Access to Cancer Treatment Act of 2013" H R 4302 "Protecting Access to Medicare Act of 2014" (PL 113-93)
Client expense: Not reported · Firm income: $60,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2014 · second_quarter · Medicare/Medicaid
Physician and pharmacy reimbursement issues. Implementation of the Affordable Care Act. H.R. 2869 "Medicare Patient Access to Cancer Treatment Act of 2013" H.R. 1416 "Cancer Patient Protection Act of 2013" H.R. 4302 "Protecting Access to Medicare Act of 2014" (PL 113-93)S.806/H.R. 800 To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biological under Medicare
Client expense: $250,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2014 · second_quarter · Health Issues
HR 800, prompt pay legislation; health IT and meaningful use; radiation and reimbursement issues; SGR Medicare physician payments; H.R.1416 Cancer Patient Protection Act of 2013; H.R. 2869, Medicare Patient Access to Cancer Treatment Act of 2013
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · second_quarter · Medicare/Medicaid
Physician and pharmacy reimbursement issues. Implementation of the Affordable Care Act. H.R. 2869 "Medicare Patient Access to Cancer Treatment Act of 2013" H.R. 1416 "Cancer Patient Protection Act of 2013" H.R. 4302 "Protecting Access to Medicare Act of 2014" (PL 113-93)S.806/H.R. 800 To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biological under Medicare
Client expense: $250,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2014 · second_quarter · Medicare/Medicaid
Physician and pharmacy reimbursement issues. Implementation of the Affordable Care Act. H.R. 2869 "Medicare Patient Access to Cancer Treatment Act of 2013" H R 4302 "Protecting Access to Medicare Act of 2014" (PL 113-93)
Client expense: Not reported · Firm income: $60,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2014 · second_quarter · Medicare/Medicaid
HR 2869, the "Medicare Patient Access to Cancer Treatment Act of 2014" - All Provisions HR 1250, the "Medicare Audit Improvement Act of 2013" - All Provisions S 1012, the "Medicare Audit Improvement Act of 2013" - All Provisions
Client expense: $110,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · second_quarter · Pharmacy
FY14 Labor-HHS Appropriations Bill, H.R. 2869, Orphan Drug Rule, ACA implementation, 340B Drug Discount Program Congressional Oversight
Client expense: $219,197 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
2014 · second_quarter · Medicare/Medicaid
Passage of the Cancer Patient Protection Act of 2013 (H.R. 1416) to stop application of the Medicare sequester cut to cancer drugs; Passage of H.R. 800 & S. 806, identical bills to stop artificial reduction of Medicare reimbursement for cancer drugs due to inclusion of manufacturer-to-distributor prompt pay discounts in the calculation of reimbursement rates; House and Senate bills and legislative efforts to fix the Medicare reimbursement system based on the sustainable growth rate (SGR) and to reform the Medicare payment system; Passage of the Medicare Access to Cancer Treatment ACT (H.R 2869) to create site payment parity between community cancer clinics and outpatient hospitals for identical cancer care services.
Client expense: $86,065 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · first_quarter · Medicare/Medicaid
Physician and pharmacy reimbursement issues. Implementation of the Affordable Care Act. H.R. 2869 "Medicare Patient Access to Cancer Treatment Act of 2013" H R 4302 "Protecting Access to Medicare Act of 2014" (PL 113-93)
Client expense: Not reported · Firm income: $70,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2014 · first_quarter · Medicare/Medicaid
Physician and pharmacy reimbursement issues. Implementation of the Affordable Care Act. H.R. 2869 "Medicare Patient Access to Cancer Treatment Act of 2013" H.R. 1416 " Cancer Patient Protection Act of 2013" H.R. 4302 "Protecting Access to Medicare Act of 2014"Medicare payment and coding for clinical laboratory tests; H.R. 4302: Protecting Access to Medicare Act of 2014, P.L. 113-93. S.806/H.R. 800 To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare.
Client expense: $425,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2014 · first_quarter · Medicare/Medicaid
Passage of the Cancer Patient Protection Act of 2013 (H.R. 1416) to stop application of the Medicare sequester cut to cancer drugs; Passage of H.R. 800 & S. 806, identical bills to stop artificial reduction of Medicare reimbursement for cancer drugs due to inclusion of manufacturer-to-distributor prompt pay discounts in the calculation of reimbursement rates; House and Senate bills and legislative efforts to fix the Medicare reimbursement system based on the sustainable growth rate (SGR) and to reform the Medicare payment system; Passage of the Medicare Access to Cancer Treatment ACT (H.R 2869) to create site payment parity between community cancer clinics and outpatient hospitals for identical cancer care services.
Client expense: $79,400 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · first_quarter · Health Issues
HR 800, prompt pay legislation; health IT and meaningful use; radiation and reimbursement issues; SGR Medicare physician payments; sequestration; H.R.1416 Cancer Patient Protection Act of 2013; H.R. 2869, Medicare Patient Access to Cancer Treatment Act of 2013
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · fourth_quarter · Medicare/Medicaid
Proposed changes to Medicare hospital reimbursement policies Medicare hospital prospective payment system H.R. 2869, "The Medicare Patient Access to Cancer Treatment Act"S. 183, Hospital Payment Fairness Act of 2013 H.R. 2053, Medicare Hospital Wage Index Equity Act"
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · fourth_quarter · Medicare/Medicaid
Legislative proposals affecting Medicare and Medicaid funding Proposed changes to Medicare hospital reimbursement policies Health Care Reform Implementation Graduate Medical Education - H.R. 1180 and S. 577, Resident Physician Shortage Reduction Act of 2013S. 183, Hospital Payment Fairness Act of 2013 H.R. 2053, Medicare Hospital Wage Index Equity Act" H.R. 297, Childrens Hospital GME Support Reauthorization Act of 2013 S. 1012 and H.R. 1250, Medicare Audit Improvement Act of 2013 H.R. 2869, "The Medicare Patient Access to Cancer Treatment Act"
Client expense: Not reported · Firm income: $200,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · fourth_quarter · Medicare/Medicaid
Legislative proposals affecting Medicare and Medicaid hospital reimbursement policies Health Information Technology Health Care Reform Implementation Medicare Graduate Medical Education PaymentsH.R. 1180 and S. 577, Resident Physician Shortage Reduction Act of 2013 H.R. 1201, Training Tomorrows Doctors Today Act H.R. 297, Childrens Hospital GME Support Reauthorization Act of 2013 S. 183, Hospital Payment Fairness Act of 2013 H.R. 2053, "Medicare Hospital Wage Index Equity Act" S. 1012 and H.R. 1250, Medicare Audit Improvement Act of 2013 H.R. 2869, "The Medicare Patient Access to Cancer Treatment Act" H.R. 3698, Two Midnight Rule Delay Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · fourth_quarter · Medicare/Medicaid
Proposed changes to Medicare hospital reimbursement policies Medicare hospital prospective payment system H.R. 2869, "The Medicare Patient Access to Cancer Treatment Act"S. 183, Hospital Payment Fairness Act of 2013 H.R. 2053, Medicare Hospital Wage Index Equity Act"
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · fourth_quarter · Small Business
Impact of hospital consolidation on health care industry, health care costs, and on small business in particular independent doctors. Medicare Data Access for Transparency and Accountability Act (S.1180) Proposed repeal of In Office Ancillary Services Exception (IOASE) in FY2014 budget. HHS efforts to provide greater transparency to consumers. Importance of independent doctors, to competition, jobs, health care quality and cost. The Medicare Patient Access to Cancer Treatment Act (H.R. 2869). Calendar Year (CY) 2014 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System Policy Changes and Payment Rates (CMS-P-1601), and Proposed Policy and Payment Changes to the Medicare Physician Fee Schedule for Calendar Year 2014 (CMS-P-1600). SGR Reform bill (SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013). MedPAC recommendations regarding reimbursement parity between hospital outpatient departments and independent doctor practices. Appropriateness of tax-exempt status of certain non-profit hospitals.
Client expense: Not reported · Firm income: $20,000
Government targets: Federal Trade Commission (FTC), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2013 · fourth_quarter · Medical/Disease Research/Clinical Labs
Impact of hospital consolidation on health care industry, health care costs, and on small business in particular independent doctors. Medicare Data Access for Transparency and Accountability Act (S.1180) Proposed repeal of In Office Ancillary Services Exception (IOASE) in FY2014 budget. HHS efforts to provide greater transparency to consumers. Importance of independent doctors, to competition, jobs, health care quality and cost. The Medicare Patient Access to Cancer Treatment Act (H.R. 2869). Calendar Year (CY) 2014 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System Policy Changes and Payment Rates (CMS-P-1601), and Proposed Policy and Payment Changes to the Medicare Physician Fee Schedule for Calendar Year 2014 (CMS-P-1600). SGR Reform bill (SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013). MedPAC recommendations regarding reimbursement parity between hospital outpatient departments and independent doctor practices. Appropriateness of tax-exempt status of certain non-profit hospitals.
Client expense: Not reported · Firm income: $20,000
Government targets: Federal Trade Commission (FTC), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2013 · fourth_quarter · Medicare/Medicaid
Impact of hospital consolidation on health care industry, health care costs, and on small business in particular independent doctors. Medicare Data Access for Transparency and Accountability Act (S.1180) Proposed repeal of In Office Ancillary Services Exception (IOASE) in FY2014 budget. HHS efforts to provide greater transparency to consumers. Importance of independent doctors, to competition, jobs, health care quality and cost. The Medicare Patient Access to Cancer Treatment Act (H.R. 2869). Calendar Year (CY) 2014 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System Policy Changes and Payment Rates (CMS-P-1601), and Proposed Policy and Payment Changes to the Medicare Physician Fee Schedule for Calendar Year 2014 (CMS-P-1600). SGR Reform bill (SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013). MedPAC recommendations regarding reimbursement parity between hospital outpatient departments and independent doctor practices. Appropriateness of tax-exempt status of certain non-profit hospitals.
Client expense: Not reported · Firm income: $20,000
Government targets: Federal Trade Commission (FTC), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2013 · fourth_quarter · Health Issues
Impact of hospital consolidation on health care industry, health care costs, and on small business in particular independent doctors. Medicare Data Access for Transparency and Accountability Act (S.1180) Proposed repeal of In Office Ancillary Services Exception (IOASE) in FY2014 budget. HHS efforts to provide greater transparency to consumers. Importance of independent doctors, to competition, jobs, health care quality and cost. The Medicare Patient Access to Cancer Treatment Act (H.R. 2869). Calendar Year (CY) 2014 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System Policy Changes and Payment Rates (CMS-P-1601), and Proposed Policy and Payment Changes to the Medicare Physician Fee Schedule for Calendar Year 2014 (CMS-P-1600). SGR Reform bill (SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013). MedPAC recommendations regarding reimbursement parity between hospital outpatient departments and independent doctor practices. Appropriateness of tax-exempt status of certain non-profit hospitals.
Client expense: Not reported · Firm income: $20,000
Government targets: Federal Trade Commission (FTC), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2013 · fourth_quarter · Medicare/Medicaid
Physician and pharmacy reimbursement issues. Implementation of the Affordable Care Act. H.R. 2869 "Medicare Patient Access to Cancer Treatment Act of 2013"
Client expense: Not reported · Firm income: $70,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · fourth_quarter · Pharmacy
FY14 Labor-HHS Appropriations Bill, Medicare Part B Drug Reimbursement, H.R. 2869, Orphan Drug Rule, ACA implementation, SGR reform pay-fors, 340B Drug Discount Program Congressional Oversight
Client expense: $232,014 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
2013 · fourth_quarter · Medicare/Medicaid
Physician and pharmacy reimbursement issues. Implementation of the Affordable Care Act. H.R. 2869 "Medicare Patient Access to Cancer Treatment Act of 2013" H.R. 1416 "Cancer Patient Protection Act of 2013"S.806/H.R. 800 To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare.
Client expense: $560,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2013 · fourth_quarter · Medicare/Medicaid
Legislative proposals affecting Medicare and Medicaid funding Proposed changes to Medicare hospital reimbursement policies Health Care Reform Implementation Graduate Medical Education - H.R. 1180 and S. 577, Resident Physician Shortage Reduction Act of 2013S. 183, Hospital Payment Fairness Act of 2013 H.R. 2053, Medicare Hospital Wage Index Equity Act" H.R. 297, Childrens Hospital GME Support Reauthorization Act of 2013 S. 1012 and H.R. 1250, Medicare Audit Improvement Act of 2013 H.R. 2869, "The Medicare Patient Access to Cancer Treatment Act"
Client expense: Not reported · Firm income: $200,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · fourth_quarter · Medicare/Medicaid
Legislative proposals affecting Medicare and Medicaid hospital reimbursement policies Health Information Technology Health Care Reform Implementation Medicare Graduate Medical Education PaymentsH.R. 1180 and S. 577, Resident Physician Shortage Reduction Act of 2013 H.R. 1201, Training Tomorrows Doctors Today Act H.R. 297, Childrens Hospital GME Support Reauthorization Act of 2013 S. 183, Hospital Payment Fairness Act of 2013 H.R. 2053, "Medicare Hospital Wage Index Equity Act" S. 1012 and H.R. 1250, Medicare Audit Improvement Act of 2013 H.R. 2869, "The Medicare Patient Access to Cancer Treatment Act" H.R. 3698, Two Midnight Rule Delay Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · fourth_quarter · Medicare/Medicaid
Proposed changes to Medicare hospital reimbursement policies Medicare hospital prospective payment system H.R. 2869, "The Medicare Patient Access to Cancer Treatment Act"S. 183, Hospital Payment Fairness Act of 2013 H.R. 2053, Medicare Hospital Wage Index Equity Act"
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · fourth_quarter · Health Issues
H.R. 1250/S. 1012, The Medicare Audit Improvement Act of 2013 H.R. 1920/S. 1555, The DSH Reduction Relief Act H.R. 2810, Medicare Patient Access and Quality Improvement Act of 2013 H.R. 2869, Medicare Patient Access to Cancer Treatment Act of 2013H.R. 3531, Creating Access to Rehabilitation for Every Senior (CARES) Act of 2013 H.R. 3750, The Telehealth Modernization Act of 2013 H.J. Res. 59, Continuing Appropriations Resolution, 2014 CMS-1443-P Medicare Program; Prospective Payment System for Federally Qualified Health Centers; Changes to Contracting Policies for Rural Health Clinics; and Changes to Clinical Laboratory Improvement Amendments of 1988 Enforcement Actions for Proficiency Testing Referral; Proposed Rule
Client expense: $235,140 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2013 · fourth_quarter · Health Issues
HR 800, prompt pay legislation; health IT and meaningful use; radiation and reimbursement issues; SGR Medicare physician payments; sequestration; H.R.1416 Cancer Patient Protection Act of 2013; H.R. 2869, Medicare Patient Access to Cancer Treatment Act of 2013
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · fourth_quarter · Medicare/Medicaid
Medicare, oncology, Radiation and Imaging issues; medicare physician payments (HR 2869); Health IT; sequestration and cancer drug reimbursement (H.R.1416); prompt pay discount (HR 800 Prompt Pay Discount Legislation); safety and security of the prescription drug supply chain;
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · third_quarter · Medicare/Medicaid
Physician and pharmacy reimbursement issues. Implementation of the Affordable Care Act. H.R. 2869 "Medicare Patient Access to Cancer Treatment Act of 2013"
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · third_quarter · Medicare/Medicaid
Legislative proposals affecting Medicare and Medicaid funding Proposed changes to Medicare hospital reimbursement policies Health Care Reform Implementation Graduate Medical Education - H.R. 1180 and S. 577, Resident Physician Shortage Reduction Act of 2013S. 183, Hospital Payment Fairness Act of 2013 H.R. 2053, Medicare Hospital Wage Index Equity Act" H.R. 297, Childrens Hospital GME Support Reauthorization Act of 2013 S. 1012 and H.R. 1250, Medicare Audit Improvement Act of 2013 H.R. 2869, "The Medicare Patient Access to Cancer Treatment Act"
Client expense: Not reported · Firm income: $200,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · third_quarter · Medicare/Medicaid
Legislative proposals affecting Medicare and Medicaid hospital reimbursement policies Health Information Technology Health Care Reform Implementation Medicare Graduate Medical Education PaymentsH.R. 1180 and S. 577, Resident Physician Shortage Reduction Act of 2013 H.R. 1201, Training Tomorrows Doctors Today Act H.R. 297, Childrens Hospital GME Support Reauthorization Act of 2013 S. 183, Hospital Payment Fairness Act of 2013 H.R. 2053, "Medicare Hospital Wage Index Equity Act" S. 1012 and H.R. 1250, Medicare Audit Improvement Act of 2013 H.R. 2869, "The Medicare Patient Access to Cancer Treatment Act"
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · third_quarter · Medicare/Medicaid
Proposed changes to Medicare hospital reimbursement policies Medicare hospital prospective payment system H.R. 2869, "The Medicare Patient Access to Cancer Treatment Act"S. 183, Hospital Payment Fairness Act of 2013 H.R. 2053, Medicare Hospital Wage Index Equity Act"
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · third_quarter · Medicare/Medicaid
Physician and pharmacy reimbursement issues. Implementation of the Affordable Care Act. H.R. 2869 "Medicare Patient Access to Cancer Treatment Act of 2013" H.R. 1416 "Cancer Patient Protection Act of 2013"S.806/H.R. 800 To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare.
Client expense: $290,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2013 · third_quarter · Medical/Disease Research/Clinical Labs
Impact of hospital consolidation on health care industry, health care costs, and on small business in particular independent doctors. Medicare Data Access for Transparency and Accountability Act (S.1180) Proposed repeal of In Office Ancillary Services Exception (IOASE) in FY2014 budget. HHS efforts to provide greater transparency to consumers. Importance of independent doctors, to competition, jobs, health care quality and cost. The Medicare Patient Access to Cancer Treatment Act (H.R. 2869). Calendar Year (CY) 2014 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System Policy Changes and Payment Rates (CMS-P-1601), and Proposed Policy and Payment Changes to the Medicare Physician Fee Schedule for Calendar Year 2014 (CMS-P-1600).
Client expense: Not reported · Firm income: $20,000
Government targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2013 · third_quarter · Medicare/Medicaid
Impact of hospital consolidation on health care industry, health care costs, and on small business in particular independent doctors. Medicare Data Access for Transparency and Accountability Act (S.1180) Proposed repeal of In Office Ancillary Services Exception (IOASE) in FY2014 budget. HHS efforts to provide greater transparency to consumers. Importance of independent doctors, to competition, jobs, health care quality and cost. The Medicare Patient Access to Cancer Treatment Act (H.R. 2869). Calendar Year (CY) 2014 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System Policy Changes and Payment Rates (CMS-P-1601), and Proposed Policy and Payment Changes to the Medicare Physician Fee Schedule for Calendar Year 2014 (CMS-P-1600).
Client expense: Not reported · Firm income: $20,000
Government targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2013 · third_quarter · Health Issues
Impact of hospital consolidation on health care industry, health care costs, and on small business in particular independent doctors. Medicare Data Access for Transparency and Accountability Act (S.1180) Proposed repeal of In Office Ancillary Services Exception (IOASE) in FY2014 budget. HHS efforts to provide greater transparency to consumers. Importance of independent doctors, to competition, jobs, health care quality and cost. The Medicare Patient Access to Cancer Treatment Act (H.R. 2869). Calendar Year (CY) 2014 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System Policy Changes and Payment Rates (CMS-P-1601), and Proposed Policy and Payment Changes to the Medicare Physician Fee Schedule for Calendar Year 2014 (CMS-P-1600).
Client expense: Not reported · Firm income: $20,000
Government targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2013 · third_quarter · Small Business
Impact of hospital consolidation on health care industry, health care costs, and on small business in particular independent doctors. Medicare Data Access for Transparency and Accountability Act (S.1180) Proposed repeal of In Office Ancillary Services Exception (IOASE) in FY2014 budget. HHS efforts to provide greater transparency to consumers. Importance of independent doctors, to competition, jobs, health care quality and cost. The Medicare Patient Access to Cancer Treatment Act (H.R. 2869). Calendar Year (CY) 2014 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System Policy Changes and Payment Rates (CMS-P-1601), and Proposed Policy and Payment Changes to the Medicare Physician Fee Schedule for Calendar Year 2014 (CMS-P-1600).
Client expense: Not reported · Firm income: $20,000
Government targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2013 · third_quarter · Medicare/Medicaid
HR 2869 The Medicare Patient Access to Cancer Treatment Act of 2013.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · third_quarter · Medicare/Medicaid
H.R. 2869, the Medicare Patient Access to Cancer Treatment Act, issues pertaining to Medicare hospital outpatient payments.
Client expense: $180,000 · Firm income: Not reported
Government targets: Defense Intelligence Agency (DIA), HOUSE OF REPRESENTATIVES, SENATE
2013 · third_quarter · Medicare/Medicaid
HR 2869 The Medicare Patient Access to Cancer Treatment Act of 2013
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES
2013 · third_quarter · Pharmacy
- The 340B Drug Discount program - Medicare Part B Drug Reimbursement, H.R. 2869 - Orphan Drug Rule, ACA implementation - SGR reform pay-fors
Client expense: $231,546 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE